Sort
39,280 grants matching “leukemia”
Regulation of Mast Cell Function by Inhibitory Molecules
$309,063Anna Huttenlocher · University Of Wisconsin-Madison · R01 · FY2009 · AI
Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
$309,000Rintaro Hashizume · Northwestern University At Chicago · R01 · FY2017 · NS
Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
$309,000Rintaro Hashizume · Northwestern University At Chicago · R01 · FY2016 · NS
Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
$309,000Rintaro Hashizume · Northwestern University At Chicago · R01 · FY2015 · NS
Institute for Clinical and Translational Science
$309,000Dan M Cooper · University Of California-Irvine · UL1 · FY2017 · TR
Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
$309,000Rintaro Hashizume · Northwestern University At Chicago · R01 · FY2019 · NS
Collaborative Research: Chemical Hydrogeologic Investigations of Tungsten: Field, Laboratory, and Modeling Studies of an Emerging Environmental Contaminant
$308,979Karen H Johannesson · Tulane University · · FY2010 · GEO
Role of Pbx Protein in Hematopoiesis and Growth Control
$308,970Stanford University · R01 · FY2003 · CA
Chemical Inhibitors of CREB-mediated Gene Transcription
$308,961Xiangshu Xiao · Oregon Health & Science University · R01 · FY2013 · GM
Novel Compounds to Inactivate Oncogenic Fusion Proteins
$308,958Jeffrey A Toretsky · Georgetown University · R01 · FY2012 · CA
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
$308,958Laura Maria Calvi · University Of Rochester · R01 · FY2014 · CA
Novel Compounds to Inactivate Oncogenic Fusion Proteins
$308,958Jeffrey A Toretsky · Georgetown University · R01 · FY2011 · CA
Targeting the aberrant kinome-epigenome in AML
$308,958Ramiro Garzon · Ohio State University · R01 · FY2016 · CA
Role of microRNAs in the regulation of CML stem cell self renewal and survival
$308,958Danilo Perrotti · University Of Maryland Baltimore · R01 · FY2014 · CA
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
$308,903David A Fruman · University Of California-Irvine · R01 · FY2016 · CA
CHROMOSOME ARCHITECTURE AND DOMAINS OF REPRESSION
$308,900Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2001 · GM
Studies of other risk factors for radiosensitive tumors
$308,895Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
$308,891Michael A. Farrar · University Of Minnesota · R01 · FY2011 · CA
Translational Investigation of KRas & NF1 in Myeloid Leukemia
$308,865Kevin M Shannon · University Of California, San Francisco · R37 · FY2007 · CA
Characterization of Myeloid Tumor Suppressor Genes on Chromosome 5
$308,860Michelle M Le Beau · University Of Chicago · P01 · FY2009 · CA
Regulation of hematopoietic stem cell differentiation
$308,858Iannis Aifantis · New York University School Of Medicine · R01 · FY2010 · CA
CLINCIAL VALIDATION OF APC AND TP53 AS BIOMARKERS FOR CETUXIMAB RESPONSE
$308,813Timothy J Yeatman · University Of Utah · UH3 · FY2021 · CA
Nuclear Transport Factors in Chromosomal Instability
$308,790Mayo Clinic · R01 · FY2005 · CA
Nuclear Transport Factors in Chromosomal Instability
$308,790Mayo Clinic · R01 · FY2004 · CA
Nuclear Transport Factors in Chromosomal Instability
$308,790Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · CA